Cargando…

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis

All currently licensed medications for multiple sclerosis (MS) target the immune system. Albeit promising preclinical results demonstrated disease amelioration and remyelination enhancement via modulating oligodendrocyte lineage cells, most drug candidates showed only modest or no effects in human c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xinda, Jacob, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093908/ https://www.ncbi.nlm.nih.gov/pubmed/37047344 http://dx.doi.org/10.3390/ijms24076373

Ejemplares similares

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
por: Schultz, Verena, et al.
Publicado: (2017)

7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
por: Kolb, Hadar, et al.
Publicado: (2021)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis
por: Anastasiadou, Sofia, et al.
Publicado: (2015)

New ex vivo demyelination/remyelination models to defeat multiple sclerosis and neuromyelitis optica
por: Liu, Yiting
Publicado: (2019)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Butyrate suppresses demyelination and enhances remyelination
por: Chen, Tong, et al.
Publicado: (2019)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes
por: Chu, Tianci, et al.
Publicado: (2020)

Role of Multifocal Visually Evoked Potential as a Biomarker of Demyelination, Spontaneous Remyelination, and Myelin Repair in Multiple Sclerosis
por: Klistorner, Alexandr, et al.
Publicado: (2021)

Demyelination and remyelination detected in an alternative cuprizone mouse model of multiple sclerosis with 7.0 T multiparameter magnetic resonance imaging
por: Ding, Shuang, et al.
Publicado: (2021)

Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography
por: Bodini, Benedetta, et al.
Publicado: (2016)

A New Model of Cuprizone-Mediated Demyelination/Remyelination
por: Sachs, Hilary H., et al.
Publicado: (2014)

An Alternative Cuprizone-Induced Demyelination and Remyelination Mouse Model
por: Zhen, Wei, et al.
Publicado: (2017)

In Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination
por: Merrill, Jean E
Publicado: (2008)

Effect of Fasudil on remyelination following cuprizone‐induced demyelination
por: Wang, Jing, et al.
Publicado: (2019)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis
por: Ghareghani, Majid, et al.
Publicado: (2022)

Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
por: Ben-Shalom, Ido, et al.
Publicado: (2021)

Demyelination in multiple sclerosis
por: Lubetzki, Catherine, et al.
Publicado: (2014)

Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease
por: Hertzog, Nadège, et al.
Publicado: (2023)

In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination
Publicado: (1990)

Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination
por: Hibbits, Norah, et al.
Publicado: (2012)

Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination
por: Kim, Suhyun, et al.
Publicado: (2015)

Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model
por: Tagge, Ian, et al.
Publicado: (2016)

Retraction: Effect of Fasudil on remyelination following cuprizone‐induced demyelination.
por: Wang, Jing, et al.
Publicado: (2020)

Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model
por: Gingele, Stefan, et al.
Publicado: (2020)

Oligodendroglial primary cilium heterogeneity during development and demyelination/remyelination
por: Delfino, Giada, et al.
Publicado: (2022)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vi97a0vkbv0iif6p227cjc7s5n